Clinical Trial Update: A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing selumetinib to carboplatin and vincristine in patients with low-grade glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Astrocytoma
• Low-grade Glioma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Selumetinib (selumetinib)
• Vincristine (vincristine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Low Grade Astrocytoma, Low Grade Glioma | Phase 3 | Status: RECRUITING